289 related articles for article (PubMed ID: 23653887)
1. Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies.
Potts MB; Silvestrini MT; Lim DA
Surg Neurol Int; 2013; 4(Suppl 1):S22-30. PubMed ID: 23653887
[TBL] [Abstract][Full Text] [Related]
2. Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: A review.
Bellotti E; Schilling AL; Little SR; Decuzzi P
J Control Release; 2021 Jan; 329():16-35. PubMed ID: 33259851
[TBL] [Abstract][Full Text] [Related]
3. Radially branched deployment for more efficient cell transplantation at the scale of the human brain.
Silvestrini MT; Yin D; Coppes VG; Mann P; Martin AJ; Larson PS; Starr PA; Gupta N; Panter SS; Desai TA; Lim DA
Stereotact Funct Neurosurg; 2013; 91(2):92-103. PubMed ID: 23343609
[TBL] [Abstract][Full Text] [Related]
4. Recent Trends in Nanotechnology Toward CNS Diseases: Lipid-Based Nanoparticles and Exosomes for Targeted Therapeutic Delivery.
Cardoso AM; Guedes JR; Cardoso AL; Morais C; Cunha P; Viegas AT; Costa R; Jurado A; Pedroso de Lima MC
Int Rev Neurobiol; 2016; 130():1-40. PubMed ID: 27678173
[TBL] [Abstract][Full Text] [Related]
5. Current strategies for therapeutic drug delivery after traumatic CNS injury.
Lee HJ; Ryu JS; Vig PJ
Ther Deliv; 2019 Apr; 10(4):251-263. PubMed ID: 30991923
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery to the central nervous system: a review.
Misra A; Ganesh S; Shahiwala A; Shah SP
J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic nanoplatforms and delivery strategies for neurological disorders.
Kang YJ; Cutler EG; Cho H
Nano Converg; 2018 Nov; 5(1):35. PubMed ID: 30499047
[TBL] [Abstract][Full Text] [Related]
8. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
9. CNS drug delivery systems: novel approaches.
Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
[TBL] [Abstract][Full Text] [Related]
10. Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.
Vuillemenot BR; Korte S; Wright TL; Adams EL; Boyd RB; Butt MT
Toxicol Sci; 2016 Jul; 152(1):3-9. PubMed ID: 27354708
[TBL] [Abstract][Full Text] [Related]
11. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
12. Bioinspired Approaches for Central Nervous System Targeted Gene Delivery.
Kumar J; Karim A; Sweety UH; Sarma H; Nurunnabi M; Narayan M
ACS Appl Bio Mater; 2023 Dec; ():. PubMed ID: 38100377
[TBL] [Abstract][Full Text] [Related]
13. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
14. A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system.
Cook RL; Householder KT; Chung EP; Prakapenka AV; DiPerna DM; Sirianni RW
J Control Release; 2015 Dec; 220(Pt A):89-97. PubMed ID: 26471392
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal delivery of Macromolecules: Clinical status and emerging technologies.
Ajeeb R; Clegg JR
Adv Drug Deliv Rev; 2023 Aug; 199():114949. PubMed ID: 37286086
[TBL] [Abstract][Full Text] [Related]
16. Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics.
Akhtar A; Andleeb A; Waris TS; Bazzar M; Moradi AR; Awan NR; Yar M
J Control Release; 2021 Feb; 330():1152-1167. PubMed ID: 33197487
[TBL] [Abstract][Full Text] [Related]
17. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
Barchet TM; Amiji MM
Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
[TBL] [Abstract][Full Text] [Related]
18. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.
Joshi CR; Labhasetwar V; Ghorpade A
J Neuroimmune Pharmacol; 2017 Mar; 12(1):51-83. PubMed ID: 28160121
[TBL] [Abstract][Full Text] [Related]
19. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
20. Insights From Dynamic Neuro-Immune Imaging on Murine Immune Responses to CNS Damage.
Dorand RD; Benson BL; Huang LF; Petrosiute A; Huang AY
Front Neurosci; 2019; 13():737. PubMed ID: 31379488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
